Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00810264 · ClinicalTrials.gov registry record
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
A clinical trial, sponsored by Biotronik.
- Completed
- Registry status
- 2,499
- Enrollment target
NCT00810264 is a clinical trial that has completed, run by Biotronik. The registered enrollment target is 2,499 participants.
The verdict
NCT00810264 has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- 2,499 participants
- Enrollment target
Study Summary
The objective of this study is to confirm the long-term safety and reliability of the Corox OTW BP left ventricular (LV) pacing lead. As a condition of approval, the FDA required that a registry documenting the post approval clinical experience of these leads be designed and implemented.
Interventions
- DEVICE CRT Therapy - LV Lead Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,499 participants |
| Start Date | 2008-12 |
| Est. Completion | 2018-11-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00810264
The ClinicalTrials.gov registry entry for NCT00810264 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,499 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CRT Therapy - LV Lead Registry is the first listed.
NCT00810264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00810264 about?
NCT00810264 is a clinical study titled "Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar". The objective of this study is to confirm the long-term safety and reliability of the Corox OTW BP left ventricular (LV) pacing lead. As a condition of approval, the FDA required that a registry documenting the post approval clinical experience of these leads be designed and implemented.
What is the current status of trial NCT00810264?
This trial is currently completed. The enrollment target is 2,499 participants. The study started on 2008-12. Estimated completion is 2018-11-02.
What interventions are being tested in trial NCT00810264?
The interventions under investigation include: CRT Therapy - LV Lead Registry (DEVICE).
Who is sponsoring clinical trial NCT00810264?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.